Improving Postoperative Surgical Wound Dressing Outcomes
;
Despite advances in surgical techniques, surgical site infections (SSI) and other surgical site complications (SSC) continue to be a challenge to clinicians and researchers across the globe.¹
SSCs and SSIs threaten outcomes in all surgical procedures. However, the right post-op dressing plays an integral role in patient recovery and their healing process.
The advancement of postoperative wound dressings has been driven by practical clinical innovation aimed at reducing complications such as surgical site infection (SSI), dehiscence and blistering.
The Jubilee Method shows reduction in blistering
One such development in the battle against SSCs was the “Jubilee dressing method”. Created at the Golden Jubilee National Hospital in Clydebank, Scotland, where clinicians layered 3–4 Aquacel™ dressings beneath a DuoDERM™ Extra Thin hydrocolloid, an ideal dressing for surgical incisions.²
The Jubilee Method arose after clinicians saw many blisters from traditional adhesive dressings. This led the team to pilot a new multilayer dressing, combining a Hydrofiber™ Aquacel™ layer with DuoDERM™ Extra Thin. This early audit showed a reduction in blistering from 19.5% to 3.5%, prompting broader evaluation of the approach.³

Image from study: The Jubilee method: a modern dressing design which reduces complications and is cost-effective following total hip and knee arthroplasty. Dillon JM, Clarke JV, Emmerson S, Kinninmonth AWG. Department of Orthopaedics, Golden Jubilee National Hospital, Clydebank, Glasgow, Scotland.
A subsequent prospective audit compared the “Jubilee Method” with their traditional adhesive dressing. The results showed a reduction in blistering from 18% to 2%, fewer dressing changes, longer wear times, fewer delays in discharge due to wound issues, and a lower rate of surgical site infection (3% to 1%).
These findings confirmed the clinical advantages of the Hydrofiber™ and hydrocolloid combination and supported its adoption.³
Inspired by these findings, Aquacel™ Surgical and Aquacel™ Ag Surgical were developed to combine the trusted technologies of Aquacel™ Hydrofiber™ technology with DuoDERM™ hydrocolloid, addressing the key challenges of surgical recovery and reducing the risk of blistering.

Supporting patients postoperative recovery
The Aquacel Surgical range of wound dressings are designed to offer patients a range of benefits throughout their wound healing recovery process and help to facilitate a reduced length of stay.
Stays in place
Dressings stay in place for up to 7-days helping you to minimise unnecessary dressing changes⁴ to keep the incision undisturbed and promote easier self care.²
Protects against contamination
The occlusive dressing design keeps the incision protected from external contamination and is viral, bacterial and waterproof allowing your patient to shower.⁵
Hydrofiber Technology provides infection control
The fibres within the hydrofiber technology form a cohesive gel, encapsulating large populations of potentially pathogenic bacteria, reducing the risk of infection.⁶
Aquacel Surgical Wound Dressings
Aquacel™ Surgical and Aquacel™ Ag Surgical dressings were developed in response to a defined customer need for a dressing to manage wounds as a result of surgical incision.²
The Aquacel™ Surgical dressing portfolio has a strong clinical heritage in supporting physicians to reduce the harmful consequences of SSCs demonstrated across multiple surgical studies and specialties.
Aquacel™ Ag has the added benefit of ionic silver, that provides rapid and sustained anti-microbial activity and kills a broad range of pathogens within 30 minutes.⁷ Aquacel™ Ag Surgical is highly effective in providing fast and sustained anti-microbial activity against the most common SSI-associated pathogens.⁸
1. Sandy-Hodgetts K et al (2022) Optimising prevention of surgical wound complications: Detection, diagnosis and prediction. London: Wounds International. Available online at: www.woundsinternational.com
2. Product Monograph AQUACEL® Surgical Dressing Portfolio. Data on file, ConvaTec Inc.
3. Clarke JV, Deakin AH, Dillon JM, Emmerson S, Kinninmonth AW. A prospective clinical audit of a new dressing design for lower limb arthroplasty wounds. J Wound Care. 2009 Jan;18(1):5-8, 10-1. doi: 10.12968/jowc.2009.18.1.32128. PMID: 19131911.
4. Springer BD, Beaver WB, Griffin WL, Mason JB, Odum SM. Role of Surgical Dressings in Total Joint Arthroplasty: A Randomized Controlled Trial. Am J Orthop (Belle Mead NJ). 2015 Sep;44(9):415-20.
5. In-Vitro Performance Characteristics of AQUACEL® Ag Advantage Surgical Cover Dressing (SCD) and AQUACEL® Ag Advantage Surgical Cover Dressing (SCD) Slim Profile (SP) WHRI6551 MS171 V1.0. Convatec data on file
6. Walker M, Hobot JA, Newman GR, Bowler PG. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethyl cellulose (Aquacel) and alginate dressings. Biomaterials. 2003;24(5):883 890
7. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver‐ containing Hydrofiber dressing. Wound Repair Regen.2004; 12(3): 288‐29
8. Jones S, Bowler PG, Walker M. Antimicrobial activity of silver- containing dressings is influenced by dressing conformability with a wound surface. WOUNDS. 2005;17(9):263-270
AP-79844-GBR-ENG-v1
Blogs